INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 160 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $124,580 | -38.6% | 11,264 | -23.3% | 0.00% | – |
Q2 2022 | $203,000 | +9.7% | 14,691 | +29.5% | 0.00% | – |
Q1 2022 | $185,000 | -56.2% | 11,347 | -33.7% | 0.00% | -100.0% |
Q4 2020 | $422,000 | +46.5% | 17,104 | +146.1% | 0.00% | 0.0% |
Q3 2020 | $288,000 | -20.2% | 6,949 | -7.7% | 0.00% | 0.0% |
Q2 2020 | $361,000 | +8.4% | 7,526 | +178.9% | 0.00% | 0.0% |
Q4 2019 | $333,000 | +3.4% | 2,698 | -44.3% | 0.00% | 0.0% |
Q3 2019 | $322,000 | +24.8% | 4,842 | +107.9% | 0.00% | 0.0% |
Q1 2019 | $258,000 | +13.2% | 2,329 | +2.7% | 0.00% | 0.0% |
Q4 2018 | $228,000 | -60.4% | 2,268 | -4.9% | 0.00% | -50.0% |
Q2 2015 | $576,000 | +66.0% | 2,386 | +94.3% | 0.00% | 0.0% |
Q1 2015 | $347,000 | +57.0% | 1,228 | -13.4% | 0.00% | +100.0% |
Q4 2014 | $221,000 | – | 1,418 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |